ArticleScientific reports2021

Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis.

Jun Miyoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.